|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400084828 |
|
最近更新日期: Date of Last Refreshed on: |
2024-05-24 18:24:03 |
|
注册时间: Date of Registration: |
2024-05-24 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
建立与验证经皮椎间孔镜髓核摘除术治疗腰椎间盘突出症术后复发的风险预测模型 |
|
Public title: |
Development and Validation of a risk prediction model for postoperative recurrence of percutaneous endoscopic discectomy in the treatment of lumbar disc herniation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
建立与验证经皮椎间孔镜髓核摘除术治疗腰椎间盘突出症术后复发的风险预测模型 |
|
Scientific title: |
Development and Validation of a risk prediction model for postoperative recurrence of percutaneous endoscopic discectomy in the treatment of lumbar disc herniation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈益锋 |
研究负责人: |
柳达 |
|
Applicant: |
Chen Yifeng |
Study leader: |
Liu Da |
|
申请注册联系人电话: Applicant telephone: |
+86 191 1580 8834 |
研究负责人电话: Study leader's telephone: |
+86 189 4025 7508 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
doctorcyf616@163.com |
研究负责人电子邮件: Study leader's E-mail: |
spinecmu@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国辽宁省沈阳市沈北新区蒲河大道16号 |
研究负责人通讯地址: |
中国辽宁省沈阳市沈北新区蒲河大道16号 |
|
Applicant address: |
No. 16, Puhe Avenue, Shenbei New District, Shenyang, Liaoning, China |
Study leader's address: |
No. 16, Puhe Avenue, Shenbei New District, Shenyang, Liaoning, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国医科大学附属盛京医院 |
||
|
Applicant's institution: |
Shengjing Hospital of China Medical University |
||
|
研究负责人所在单位: |
中国医科大学附属盛京医院 |
||
|
Affiliation of the Leader: |
Shengjing Hospital of China Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023PS1180K |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国医科大学附属盛京医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee, Shengjing Hospital, China Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-10-16 00:00:00 |
||
|
伦理委员会联系人: |
赵玉虹 |
||
|
Contact Name of the ethic committee: |
Zhao Yuhong |
||
|
伦理委员会联系地址: |
中国医科大学附属盛京医院 |
||
|
Contact Address of the ethic committee: |
Shengjing Hospital of China Medical University |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 24 966 151 0027 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中国医科大学附属盛京医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shengjing Hospital of China Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国辽宁省沈阳市沈北新区蒲河大道16号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 16, Puhe Avenue, Shenbei New District, Shenyang, Liaoning, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
辽宁省重点研发计划 |
||||||||||||||||||||||
|
Source(s) of funding: |
Liaoning Province Key Research and Development Project |
||||||||||||||||||||||
|
Target disease: |
lumbar disc herniation |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
探究经皮椎间孔镜髓核摘除术术后复发的危险因素,并开发一个有效的预测模型 |
||||||||||||||||||||||
|
Objectives of Study: |
Exploring risk factors for postoperative recurrence after percutaneous laminectomy for nucleus pulposus removal and developing an effective predictive model |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1. 根据临床表现和影像学特征诊断为单一节段腰椎间盘突出症的患者; 2. 有完整的影像学资料,包括X射线片、CT、MRI; 3. 无手术禁忌证且有明显的手术指征的患者 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients diagnosed with single-segment lumbar disc herniation based on clinical presentation and imaging features; 2. With complete imaging data, including X-ray film, CT, MRI; 3. Patients without contraindications to surgery and with obvious indications for surgery. |
||||||||||||||||||||||
|
排除标准: |
1. 合并心脑肾等严重器质性病变的患者; 2. 合并中枢神经系统疾病存在认知功能障碍的患者; 3. 腰椎不稳、腰椎滑脱症、先天性脊柱侧弯引起的腰椎间盘突出症患者; 4. 临床资料不全的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with severe organic lesions such as cardio-cerebral and renal diseases combined; 2. Patients with cognitive dysfunction in combination with central nervous system diseases; 3. Patients with lumbar instability, lumbar spondylolisthesis, and lumbar disc herniation caused by congenital scoliosis; 4. Patients with incomplete clinical information. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-05-01 00:00:00至 To 2023-05-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2022-05-01 00:00:00 至 To 2023-05-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
不适用 |
|
Blinding: |
N/A |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
文章发表1年后,若有必要公开原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
One years after the article was published, disclose the original data if necessary. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
采样病例记录表采集数据,采用EXCEL表管理数据。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The data were collected by case record form, and the data were managed by EXCEL table. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |